Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1061157

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1061157

Global Acromegaly Market Insights and Forecast to 2028

PUBLISHED:
PAGES: 105 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults.

Market Analysis and Insights: Global Acromegaly Market

The global Acromegaly market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Somatostatin Analogues accounting for % of the Acromegaly global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Acromegaly market size is valued at US$ million in 2021, while the North America and Europe Acromegaly are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Acromegaly landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acromegaly market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acromegaly market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acromegaly market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acromegaly market.

Global Acromegaly Scope and Market Size

Acromegaly market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Acromegaly market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Somatostatin Analogues
  • Dopamine Agonists
  • Growth Hormone Receptor Antagonists
  • Other

Segment by Application

  • Hospitals
  • Clinics

By Company

  • Novartis
  • Aegis Therapeutics
  • Chiasma
  • Crinetics Pharmaceuticals
  • Daewoong Pharmaceutical
  • Peptron
  • Silence Therapeutics
  • Strongbridge Biopharma
  • Amryt Pharma
  • Foresee Pharmaceuticals
  • Glide Pharmaceutical
  • Ionis Pharmaceuticals
  • Ipsen

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Acromegaly Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Somatostatin Analogues
    • 1.2.3 Dopamine Agonists
    • 1.2.4 Growth Hormone Receptor Antagonists
    • 1.2.5 Other
  • 1.3 Market by Application
    • 1.3.1 Global Acromegaly Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Acromegaly Market Perspective (2017-2028)
  • 2.2 Acromegaly Growth Trends by Region
    • 2.2.1 Acromegaly Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Acromegaly Historic Market Size by Region (2017-2022)
    • 2.2.3 Acromegaly Forecasted Market Size by Region (2023-2028)
  • 2.3 Acromegaly Market Dynamics
    • 2.3.1 Acromegaly Industry Trends
    • 2.3.2 Acromegaly Market Drivers
    • 2.3.3 Acromegaly Market Challenges
    • 2.3.4 Acromegaly Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Acromegaly Players by Revenue
    • 3.1.1 Global Top Acromegaly Players by Revenue (2017-2022)
    • 3.1.2 Global Acromegaly Revenue Market Share by Players (2017-2022)
  • 3.2 Global Acromegaly Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Acromegaly Revenue
  • 3.4 Global Acromegaly Market Concentration Ratio
    • 3.4.1 Global Acromegaly Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Acromegaly Revenue in 2021
  • 3.5 Acromegaly Key Players Head office and Area Served
  • 3.6 Key Players Acromegaly Product Solution and Service
  • 3.7 Date of Enter into Acromegaly Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Acromegaly Breakdown Data by Type

  • 4.1 Global Acromegaly Historic Market Size by Type (2017-2022)
  • 4.2 Global Acromegaly Forecasted Market Size by Type (2023-2028)

5 Acromegaly Breakdown Data by Application

  • 5.1 Global Acromegaly Historic Market Size by Application (2017-2022)
  • 5.2 Global Acromegaly Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Acromegaly Market Size (2017-2028)
  • 6.2 North America Acromegaly Market Size by Type
    • 6.2.1 North America Acromegaly Market Size by Type (2017-2022)
    • 6.2.2 North America Acromegaly Market Size by Type (2023-2028)
    • 6.2.3 North America Acromegaly Market Share by Type (2017-2028)
  • 6.3 North America Acromegaly Market Size by Application
    • 6.3.1 North America Acromegaly Market Size by Application (2017-2022)
    • 6.3.2 North America Acromegaly Market Size by Application (2023-2028)
    • 6.3.3 North America Acromegaly Market Share by Application (2017-2028)
  • 6.4 North America Acromegaly Market Size by Country
    • 6.4.1 North America Acromegaly Market Size by Country (2017-2022)
    • 6.4.2 North America Acromegaly Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Acromegaly Market Size (2017-2028)
  • 7.2 Europe Acromegaly Market Size by Type
    • 7.2.1 Europe Acromegaly Market Size by Type (2017-2022)
    • 7.2.2 Europe Acromegaly Market Size by Type (2023-2028)
    • 7.2.3 Europe Acromegaly Market Share by Type (2017-2028)
  • 7.3 Europe Acromegaly Market Size by Application
    • 7.3.1 Europe Acromegaly Market Size by Application (2017-2022)
    • 7.3.2 Europe Acromegaly Market Size by Application (2023-2028)
    • 7.3.3 Europe Acromegaly Market Share by Application (2017-2028)
  • 7.4 Europe Acromegaly Market Size by Country
    • 7.4.1 Europe Acromegaly Market Size by Country (2017-2022)
    • 7.4.2 Europe Acromegaly Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Acromegaly Market Size (2017-2028)
  • 8.2 Asia-Pacific Acromegaly Market Size by Type
    • 8.2.1 Asia-Pacific Acromegaly Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Acromegaly Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Acromegaly Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Acromegaly Market Size by Application
    • 8.3.1 Asia-Pacific Acromegaly Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Acromegaly Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Acromegaly Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Acromegaly Market Size by Region
    • 8.4.1 Asia-Pacific Acromegaly Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Acromegaly Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Acromegaly Market Size (2017-2028)
  • 9.2 Latin America Acromegaly Market Size by Type
    • 9.2.1 Latin America Acromegaly Market Size by Type (2017-2022)
    • 9.2.2 Latin America Acromegaly Market Size by Type (2023-2028)
    • 9.2.3 Latin America Acromegaly Market Share by Type (2017-2028)
  • 9.3 Latin America Acromegaly Market Size by Application
    • 9.3.1 Latin America Acromegaly Market Size by Application (2017-2022)
    • 9.3.2 Latin America Acromegaly Market Size by Application (2023-2028)
    • 9.3.3 Latin America Acromegaly Market Share by Application (2017-2028)
  • 9.4 Latin America Acromegaly Market Size by Country
    • 9.4.1 Latin America Acromegaly Market Size by Country (2017-2022)
    • 9.4.2 Latin America Acromegaly Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Acromegaly Market Size (2017-2028)
  • 10.2 Middle East & Africa Acromegaly Market Size by Type
    • 10.2.1 Middle East & Africa Acromegaly Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Acromegaly Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Acromegaly Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Acromegaly Market Size by Application
    • 10.3.1 Middle East & Africa Acromegaly Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Acromegaly Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Acromegaly Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Acromegaly Market Size by Country
    • 10.4.1 Middle East & Africa Acromegaly Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Acromegaly Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Company Details
    • 11.1.2 Novartis Business Overview
    • 11.1.3 Novartis Acromegaly Introduction
    • 11.1.4 Novartis Revenue in Acromegaly Business (2017-2022)
    • 11.1.5 Novartis Recent Developments
  • 11.2 Aegis Therapeutics
    • 11.2.1 Aegis Therapeutics Company Details
    • 11.2.2 Aegis Therapeutics Business Overview
    • 11.2.3 Aegis Therapeutics Acromegaly Introduction
    • 11.2.4 Aegis Therapeutics Revenue in Acromegaly Business (2017-2022)
    • 11.2.5 Aegis Therapeutics Recent Developments
  • 11.3 Chiasma
    • 11.3.1 Chiasma Company Details
    • 11.3.2 Chiasma Business Overview
    • 11.3.3 Chiasma Acromegaly Introduction
    • 11.3.4 Chiasma Revenue in Acromegaly Business (2017-2022)
    • 11.3.5 Chiasma Recent Developments
  • 11.4 Crinetics Pharmaceuticals
    • 11.4.1 Crinetics Pharmaceuticals Company Details
    • 11.4.2 Crinetics Pharmaceuticals Business Overview
    • 11.4.3 Crinetics Pharmaceuticals Acromegaly Introduction
    • 11.4.4 Crinetics Pharmaceuticals Revenue in Acromegaly Business (2017-2022)
    • 11.4.5 Crinetics Pharmaceuticals Recent Developments
  • 11.5 Daewoong Pharmaceutical
    • 11.5.1 Daewoong Pharmaceutical Company Details
    • 11.5.2 Daewoong Pharmaceutical Business Overview
    • 11.5.3 Daewoong Pharmaceutical Acromegaly Introduction
    • 11.5.4 Daewoong Pharmaceutical Revenue in Acromegaly Business (2017-2022)
    • 11.5.5 Daewoong Pharmaceutical Recent Developments
  • 11.6 Peptron
    • 11.6.1 Peptron Company Details
    • 11.6.2 Peptron Business Overview
    • 11.6.3 Peptron Acromegaly Introduction
    • 11.6.4 Peptron Revenue in Acromegaly Business (2017-2022)
    • 11.6.5 Peptron Recent Developments
  • 11.7 Silence Therapeutics
    • 11.7.1 Silence Therapeutics Company Details
    • 11.7.2 Silence Therapeutics Business Overview
    • 11.7.3 Silence Therapeutics Acromegaly Introduction
    • 11.7.4 Silence Therapeutics Revenue in Acromegaly Business (2017-2022)
    • 11.7.5 Silence Therapeutics Recent Developments
  • 11.8 Strongbridge Biopharma
    • 11.8.1 Strongbridge Biopharma Company Details
    • 11.8.2 Strongbridge Biopharma Business Overview
    • 11.8.3 Strongbridge Biopharma Acromegaly Introduction
    • 11.8.4 Strongbridge Biopharma Revenue in Acromegaly Business (2017-2022)
    • 11.8.5 Strongbridge Biopharma Recent Developments
  • 11.9 Amryt Pharma
    • 11.9.1 Amryt Pharma Company Details
    • 11.9.2 Amryt Pharma Business Overview
    • 11.9.3 Amryt Pharma Acromegaly Introduction
    • 11.9.4 Amryt Pharma Revenue in Acromegaly Business (2017-2022)
    • 11.9.5 Amryt Pharma Recent Developments
  • 11.10 Foresee Pharmaceuticals
    • 11.10.1 Foresee Pharmaceuticals Company Details
    • 11.10.2 Foresee Pharmaceuticals Business Overview
    • 11.10.3 Foresee Pharmaceuticals Acromegaly Introduction
    • 11.10.4 Foresee Pharmaceuticals Revenue in Acromegaly Business (2017-2022)
    • 11.10.5 Foresee Pharmaceuticals Recent Developments
  • 11.11 Glide Pharmaceutical
    • 11.11.1 Glide Pharmaceutical Company Details
    • 11.11.2 Glide Pharmaceutical Business Overview
    • 11.11.3 Glide Pharmaceutical Acromegaly Introduction
    • 11.11.4 Glide Pharmaceutical Revenue in Acromegaly Business (2017-2022)
    • 11.11.5 Glide Pharmaceutical Recent Developments
  • 11.12 Ionis Pharmaceuticals
    • 11.12.1 Ionis Pharmaceuticals Company Details
    • 11.12.2 Ionis Pharmaceuticals Business Overview
    • 11.12.3 Ionis Pharmaceuticals Acromegaly Introduction
    • 11.12.4 Ionis Pharmaceuticals Revenue in Acromegaly Business (2017-2022)
    • 11.12.5 Ionis Pharmaceuticals Recent Developments
  • 11.13 Ipsen
    • 11.13.1 Ipsen Company Details
    • 11.13.2 Ipsen Business Overview
    • 11.13.3 Ipsen Acromegaly Introduction
    • 11.13.4 Ipsen Revenue in Acromegaly Business (2017-2022)
    • 11.13.5 Ipsen Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Acromegaly Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Somatostatin Analogues
  • Table 3. Key Players of Dopamine Agonists
  • Table 4. Key Players of Growth Hormone Receptor Antagonists
  • Table 5. Key Players of Other
  • Table 6. Global Acromegaly Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 7. Global Acromegaly Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 8. Global Acromegaly Market Size by Region (2017-2022) & (US$ Million)
  • Table 9. Global Acromegaly Market Share by Region (2017-2022)
  • Table 10. Global Acromegaly Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 11. Global Acromegaly Market Share by Region (2023-2028)
  • Table 12. Acromegaly Market Trends
  • Table 13. Acromegaly Market Drivers
  • Table 14. Acromegaly Market Challenges
  • Table 15. Acromegaly Market Restraints
  • Table 16. Global Acromegaly Revenue by Players (2017-2022) & (US$ Million)
  • Table 17. Global Acromegaly Revenue Share by Players (2017-2022)
  • Table 18. Global Top Acromegaly by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acromegaly as of 2021)
  • Table 19. Ranking of Global Top Acromegaly Companies by Revenue (US$ Million) in 2021
  • Table 20. Global 5 Largest Players Market Share by Acromegaly Revenue (CR5 and HHI) & (2017-2022)
  • Table 21. Key Players Headquarters and Area Served
  • Table 22. Key Players Acromegaly Product Solution and Service
  • Table 23. Date of Enter into Acromegaly Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Acromegaly Market Size by Type (2017-2022) & (US$ Million)
  • Table 26. Global Acromegaly Revenue Market Share by Type (2017-2022)
  • Table 27. Global Acromegaly Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 28. Global Acromegaly Revenue Market Share by Type (2023-2028)
  • Table 29. Global Acromegaly Market Size by Application (2017-2022) & (US$ Million)
  • Table 30. Global Acromegaly Revenue Share by Application (2017-2022)
  • Table 31. Global Acromegaly Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 32. Global Acromegaly Revenue Share by Application (2023-2028)
  • Table 33. North America Acromegaly Market Size by Type (2017-2022) & (US$ Million)
  • Table 34. North America Acromegaly Market Size by Type (2023-2028) & (US$ Million)
  • Table 35. North America Acromegaly Market Size by Application (2017-2022) & (US$ Million)
  • Table 36. North America Acromegaly Market Size by Application (2023-2028) & (US$ Million)
  • Table 37. North America Acromegaly Market Size by Country (2017-2022) & (US$ Million)
  • Table 38. North America Acromegaly Market Size by Country (2023-2028) & (US$ Million)
  • Table 39. Europe Acromegaly Market Size by Type (2017-2022) & (US$ Million)
  • Table 40. Europe Acromegaly Market Size by Type (2023-2028) & (US$ Million)
  • Table 41. Europe Acromegaly Market Size by Application (2017-2022) & (US$ Million)
  • Table 42. Europe Acromegaly Market Size by Application (2023-2028) & (US$ Million)
  • Table 43. Europe Acromegaly Market Size by Country (2017-2022) & (US$ Million)
  • Table 44. Europe Acromegaly Market Size by Country (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Acromegaly Market Size by Type (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Acromegaly Market Size by Type (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Acromegaly Market Size by Application (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Acromegaly Market Size by Application (2023-2028) & (US$ Million)
  • Table 49. Asia Pacific Acromegaly Market Size by Region (2017-2022) & (US$ Million)
  • Table 50. Asia Pacific Acromegaly Market Size by Region (2023-2028) & (US$ Million)
  • Table 51. Latin America Acromegaly Market Size by Type (2017-2022) & (US$ Million)
  • Table 52. Latin America Acromegaly Market Size by Type (2023-2028) & (US$ Million)
  • Table 53. Latin America Acromegaly Market Size by Application (2017-2022) & (US$ Million)
  • Table 54. Latin America Acromegaly Market Size by Application (2023-2028) & (US$ Million)
  • Table 55. Latin America Acromegaly Market Size by Country (2017-2022) & (US$ Million)
  • Table 56. Latin America Acromegaly Market Size by Country (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Acromegaly Market Size by Type (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Acromegaly Market Size by Type (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Acromegaly Market Size by Application (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Acromegaly Market Size by Application (2023-2028) & (US$ Million)
  • Table 61. Middle East and Africa Acromegaly Market Size by Country (2017-2022) & (US$ Million)
  • Table 62. Middle East and Africa Acromegaly Market Size by Country (2023-2028) & (US$ Million)
  • Table 63. Novartis Company Details
  • Table 64. Novartis Business Overview
  • Table 65. Novartis Acromegaly Product
  • Table 66. Novartis Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 67. Novartis Recent Developments
  • Table 68. Aegis Therapeutics Company Details
  • Table 69. Aegis Therapeutics Business Overview
  • Table 70. Aegis Therapeutics Acromegaly Product
  • Table 71. Aegis Therapeutics Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 72. Aegis Therapeutics Recent Developments
  • Table 73. Chiasma Company Details
  • Table 74. Chiasma Business Overview
  • Table 75. Chiasma Acromegaly Product
  • Table 76. Chiasma Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 77. Chiasma Recent Developments
  • Table 78. Crinetics Pharmaceuticals Company Details
  • Table 79. Crinetics Pharmaceuticals Business Overview
  • Table 80. Crinetics Pharmaceuticals Acromegaly Product
  • Table 81. Crinetics Pharmaceuticals Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 82. Crinetics Pharmaceuticals Recent Developments
  • Table 83. Daewoong Pharmaceutical Company Details
  • Table 84. Daewoong Pharmaceutical Business Overview
  • Table 85. Daewoong Pharmaceutical Acromegaly Product
  • Table 86. Daewoong Pharmaceutical Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 87. Daewoong Pharmaceutical Recent Developments
  • Table 88. Peptron Company Details
  • Table 89. Peptron Business Overview
  • Table 90. Peptron Acromegaly Product
  • Table 91. Peptron Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 92. Peptron Recent Developments
  • Table 93. Silence Therapeutics Company Details
  • Table 94. Silence Therapeutics Business Overview
  • Table 95. Silence Therapeutics Acromegaly Product
  • Table 96. Silence Therapeutics Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 97. Silence Therapeutics Recent Developments
  • Table 98. Strongbridge Biopharma Company Details
  • Table 99. Strongbridge Biopharma Business Overview
  • Table 100. Strongbridge Biopharma Acromegaly Product
  • Table 101. Strongbridge Biopharma Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 102. Strongbridge Biopharma Recent Developments
  • Table 103. Amryt Pharma Company Details
  • Table 104. Amryt Pharma Business Overview
  • Table 105. Amryt Pharma Acromegaly Product
  • Table 106. Amryt Pharma Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 107. Amryt Pharma Recent Developments
  • Table 108. Foresee Pharmaceuticals Company Details
  • Table 109. Foresee Pharmaceuticals Business Overview
  • Table 110. Foresee Pharmaceuticals Acromegaly Product
  • Table 111. Foresee Pharmaceuticals Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 112. Foresee Pharmaceuticals Recent Developments
  • Table 113. Glide Pharmaceutical Company Details
  • Table 114. Glide Pharmaceutical Business Overview
  • Table 115. Glide Pharmaceutical Acromegaly Product
  • Table 116. Glide Pharmaceutical Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 117. Glide Pharmaceutical Recent Developments
  • Table 118. Ionis Pharmaceuticals Company Details
  • Table 119. Ionis Pharmaceuticals Business Overview
  • Table 120. Ionis Pharmaceuticals Acromegaly Product
  • Table 121. Ionis Pharmaceuticals Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 122. Ionis Pharmaceuticals Recent Developments
  • Table 123. Ipsen Company Details
  • Table 124. Ipsen Business Overview
  • Table 125. Ipsen Acromegaly Product
  • Table 126. Ipsen Revenue in Acromegaly Business (2017-2022) & (US$ Million)
  • Table 127. Ipsen Recent Developments
  • Table 128. Research Programs/Design for This Report
  • Table 129. Key Data Information from Secondary Sources
  • Table 130. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Acromegaly Market Share by Type: 2021 VS 2028
  • Figure 2. Somatostatin Analogues Features
  • Figure 3. Dopamine Agonists Features
  • Figure 4. Growth Hormone Receptor Antagonists Features
  • Figure 5. Other Features
  • Figure 6. Global Acromegaly Market Share by Application: 2021 VS 2028
  • Figure 7. Hospitals Case Studies
  • Figure 8. Clinics Case Studies
  • Figure 9. Acromegaly Report Years Considered
  • Figure 10. Global Acromegaly Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 11. Global Acromegaly Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Acromegaly Market Share by Region: 2021 VS 2028
  • Figure 13. Global Acromegaly Market Share by Players in 2021
  • Figure 14. Global Top Acromegaly Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acromegaly as of 2021)
  • Figure 15. The Top 10 and 5 Players Market Share by Acromegaly Revenue in 2021
  • Figure 16. North America Acromegaly Market Size YoY (2017-2028) & (US$ Million)
  • Figure 17. North America Acromegaly Market Size Market Share by Type (2017-2028)
  • Figure 18. North America Acromegaly Market Size Market Share by Application (2017-2028)
  • Figure 19. North America Acromegaly Market Size Share by Country (2017-2028)
  • Figure 20. United States Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Canada Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Europe Acromegaly Market Size YoY (2017-2028) & (US$ Million)
  • Figure 23. Europe Acromegaly Market Size Market Share by Type (2017-2028)
  • Figure 24. Europe Acromegaly Market Size Market Share by Application (2017-2028)
  • Figure 25. Europe Acromegaly Market Size Share by Country (2017-2028)
  • Figure 26. Germany Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. France Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. U.K. Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Italy Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Russia Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Nordic Countries Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific Acromegaly Market Size YoY (2017-2028) & (US$ Million)
  • Figure 33. Asia Pacific Acromegaly Market Size Market Share by Type (2017-2028)
  • Figure 34. Asia Pacific Acromegaly Market Size Market Share by Application (2017-2028)
  • Figure 35. Asia Pacific Acromegaly Market Size Share by Region (2017-2028)
  • Figure 36. China Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Japan Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. South Korea Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Southeast Asia Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. India Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Australia Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Latin America Acromegaly Market Size YoY (2017-2028) & (US$ Million)
  • Figure 43. Latin America Acromegaly Market Size Market Share by Type (2017-2028)
  • Figure 44. Latin America Acromegaly Market Size Market Share by Application (2017-2028)
  • Figure 45. Latin America Acromegaly Market Size Share by Country (2017-2028)
  • Figure 46. Mexico Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Brazil Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Middle East & Africa Acromegaly Market Size YoY (2017-2028) & (US$ Million)
  • Figure 49. Middle East and Africa Acromegaly Market Size Market Share by Type (2017-2028)
  • Figure 50. Middle East and Africa Acromegaly Market Size Market Share by Application (2017-2028)
  • Figure 51. Middle East and Africa Acromegaly Market Size Share by Country (2017-2028)
  • Figure 52. Turkey Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Saudi Arabia Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. UAE Acromegaly Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Novartis Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 56. Aegis Therapeutics Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 57. Chiasma Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 58. Crinetics Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 59. Daewoong Pharmaceutical Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 60. Peptron Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 61. Silence Therapeutics Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 62. Strongbridge Biopharma Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 63. Amryt Pharma Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 64. Foresee Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 65. Glide Pharmaceutical Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 66. Ionis Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 67. Ipsen Revenue Growth Rate in Acromegaly Business (2017-2022)
  • Figure 68. Bottom-up and Top-down Approaches for This Report
  • Figure 69. Data Triangulation
  • Figure 70. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!